gvtcx

WT23-056 Preserflo Treatment for Glaucoma Patients

Bradford Teaching Hospitals NHS Foundation Trust Published 9 Nov 2023 Contracts Finder

key details

Value£80,000
Statuscomplete
Category (CPV) 33140000
Deadline2 Oct 2023
Contract start23 Oct 2023
Contract end31 Mar 2025
Procedureopen
SME suitableNo
OCIDocds-b5fd17-7cd773bb-7b7e-4ec7-9f4d-f170e3233315

Award

SupplierValueDateStatus
Santen Uk Ltd £80,000 22 Oct 2023 active

description

The Preserflo MicroShunt is an innovative glaucoma drainage system that offers a less invasive procedure for patients with glaucoma. This procedure reduces the need for postoperative interventions and has a shorter duration of 20 minutes compared to the current 60-minute procedure. Implementing this system benefits the Trust by allowing more patients to be treated in one theatre list, enhancing patient treatment and care. Additionally, the Preserflo MicroShunt improves the quality of care, reduces patient waiting times, and decreases the need for follow-ups or inpatient stays.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
9 Nov 2023 Award (award) · 03e06ca7-045b-4db9-a1b4-63f3e4536df3-696670

more from Bradford Teaching Hospitals NHS Foundation Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.